Fundraising FoxSahsen Ventures — Full Portfolio
5 tracked investments · listed companies and verified rows first
Checkerspot uses microalgae precision fermentation to produce specialized lipids and fats, including a bio-equivalent source of the sn-2 palmitate fat found in mother's milk, rare bioactive fatty acids, and tropical fat alternatives.
BiotechClimate TechFoodTechNew MaterialsAlameda, US
Scott Franklin(Executive Officer, Director)inCharles Dimmler(Executive Officer, Director)inJohn Krzywicki(CEO)inLayla Ward(CFO)inCasey Lippmeier(CTO)inLeon Parker(SVP, Molecular Biology)in
Co-investorsBaruch Future VenturesBreakout VenturesCavallo VenturesViking GlobalBuilders VCKdT Ventures+3 more
Enzyme develops a Quality Management System (QMS) software platform for life science companies including drug, biologic, device, and digital product manufacturers, designed to streamline regulatory workflows and generate FDA-ready documentation.
Enterprise SoftwareHealthtechMedical DevicesSaaSSan Francisco, US
Jared Seehafer(Founder)inJacob Graham(Founder)in
Co-investorsDCVC (Data Collective)Soma CapitalY CombinatorAg Startup Engine SeedHack VCInformed Ventures Advisors, Llc+4 more
Outpace Bio develops engineered protein technologies and cell therapies to treat solid tumors, focusing on protein design and T cell engineering to improve cancer treatment efficacy and safety.
BiotechDeep TechMedical DevicesSeattle, US
Marc Lajoie(Founder)inScott Boyken(Founder)inStanley Riddell(Co-Founder and Scientific Advisor)Aaron Foster(Executive Officer)inCharity Scripture(Executive Officer)inEric Soller(Executive Officer)in
Co-investorsArtis VenturesRA CapitalAbstract VenturesATEL VenturesAtinum Investment Co. Ltd.Civilization Ventures Management, Llc+8 more
Parse.ly is a content analytics and audience intelligence platform offering a real-time dashboard, a content recommendation API, a data pipeline to warehouses, and AI-driven insights.
Data & InfrastructureMarketing TechMedia & Entertainment
Co-investorsFf Venture CapitalHaatchHorizon Technology FinanceJanus Henderson InvestorsSARAS CAPITALSoleus Capital
Synthesize develops generative AI models that simulate human tissue responses to drugs and diseases for clinical trial design.
AI & Machine LearningBiotechDigital Health
Robert Bradley, PhDinJeff Leek, PhDinAlice Walsh, PhDinGregory Koytiger, PhDinJeff Leek(Founder)Robert Bradley(Founder)
Co-investorsMadrona Venture GroupAI2 IncubatorInner Loop Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.